Medi-stats automated rapid lateral flow test reporting
Covid-19 is a notifiable disease, and therefore the legislation sets out the requirement that all results (negative, positive, or invalid/void) are reported. Current reporting of your lateral flow result requires numerous questions to be answered every time you repeat your test, this takes time and can encourage non-compliance. In the majority of cases testing is required twice weekly and in many cases additional forwarding of your results on to other organisation like schools and health & safety officers.
Report and forward your results all with the click of one button
Benefits of using our COVID-19 rapid test reader
The recording process to the government website is made seamless and quick
Test results are recorded and available on a mobile phone as evidence of self-testing
No lateral flow test can be recorded more than once
A countdown is started indicating when the current test expires, and the next test is due
A guardian facility is available to record children's test for school purposes
Single user is completely free
Ability to link to your preferred pharmacy supports communication of relevant health information
Management dashboard available on request
Register for free by scanning this QR code with your mobile
COMING SOON
Medi-stats health portal allows the results of COVID-19 to be captured, reported on and patients engaged with the most current health guidelines.
Medi-stats has recently partnered with Enable Biosciences for the advanced detection of a suite of molecules such as Zika, Dengue, HIV, Lymes, etc. by means of dried blood spots using ADAP PCR assay. The process has been developed to include monitoring of patients for COVID-19 within the USA. We have developed an integrated platform between healthcare professionals, laboratory testing and patient reporting.
Enable Biosciences advanced ADAP assay powered by Medi-stats digital health portal delivers high quality laboratory results in real time reporting to healthcare professionals and patients.
Value seen with the Enable Biosciences ADAP assay
ADAP assay offers laboratory quality accuracy in an easy to collect dried blood spot or saliva drop format
Primary diagnostics - early detection - 8 days post exposure
Detection of IgA, IgM and IgG - antibodies signifies SARS-CoV2 infection that causes COVID-19 disease
Provides antibody count - strength of immunity
Detect antibody’s ability to kill or neutralise SARS-CoV2 virus
100% sensitivity and 99.56% specificity
No reactivity with antibodies from related Corona viruses such as HKU1 and NL63
Neutralisation PCR assay identifies suitable convalescent plasma donors
Fully automated for high throughput analysis
FDA Listed, IVD-Ready
Reagent supply is not affected by global shortage
Value seen with the Medi-stats Health Portal
Integration into Laboratory Information Management Systems (LIMs)
Rapid reporting of results to patients and HCP's
Health reports uploaded to patient records
Direct integration with Pharmoutcomes
Long term surveillance of immune response
Patient data available for future health programmes, e.g. vaccinations programmes
Option of advanced cardiovascular and respiratory health analysis
Community pharmacy acting as the point of contact and gateway to self-care